Skip to content

Impact of Preoperative Stellate Ganglion Block on Postoperative Oxygenation Index in Cardiac Surgery Patients: A Prospective Randomized Controlled Study

Impact of Preoperative Stellate Ganglion Block on Postoperative Oxygenation Index in Cardiac Surgery Patients: A Prospective Randomized Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105168
Enrollment
Unknown
Registered
2025-06-30
Start date
2025-07-03
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative acute respiratory distress syndrome

Interventions

SGB group:A left-sided stellate ganglion block will be performed preoperatively using 5 mL of a mixed solution containing 0.375% ropivacaine and 0.5% lidocaine.
Control group:A left-sided stellate ganglion block will be performed preoperatively using 5 mL of normal saline.

Sponsors

Shanghai Changhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age > 18 years; 2.ASA physical status classification I to III; 3.Elective open cardiac valve or coronary artery surgery under cardiopulmonary bypass (CPB); 4.Voluntarily signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Body mass index (BMI) >= 30 kg/m^2; 2.Preoperative pulse oxygen saturation < 95%; 3.Left ventricular dysfunction; 4.Procedures involving deep hypothermic circulatory arrest; 5.Infective endocarditis or evidence of other active infections; 6.History of cardiac or pulmonary surgery; 7.Comorbid chronic pulmonary diseases, including COPD, pulmonary fibrosis, asthma, etc.; 8.Pulmonary infection or sepsis within 1 month before surgery; 9.Moderate to severe anemia prior to surgery; 10.Preoperative liver cirrhosis; 11.Neuromuscular disorders (e.g., thymoma, myasthenia gravis, myopathy, muscular dystrophy); 12.Allergy to local anesthetics; 13.Infection at the puncture site; 14.Coagulopathy; 15.Contralateral phrenic nerve or recurrent laryngeal nerve paralysis; 16.Glaucoma; 17.Psychiatric disorders that affect cooperation.

Design outcomes

Primary

MeasureTime frame
Oxygenation index at 24 h postoperatively;

Secondary

MeasureTime frame
Duration of postoperative mechanical ventilation;Postoperative systemic immune-inflammation index (SII);Postoperative neutrophil-to-lymphocyte ratio (NLR);Incidence of postoperative pulmonary complications;Postoperative hemoglobin level;Postoperative SOFA score;Incidence of postoperative delirium;Incidence of postoperative sleep disturbances;Postoperative nausea and vomiting (PONV) score;Postoperative pain score;Incidence of postoperative acute respiratory distress syndrome (ARDS);Incidence of postoperative arrhythmia;Incidence of postoperative mechanical circulatory support (MCS) use;Dosage of postoperative vasoactive medications;Incidence of postoperative hepatic and renal injury;Postoperative ICU length of stay;Length of hospital stay after surgery;Postoperative Quality of Recovery-15 (QoR-15) score;

Countries

China

Contacts

Public ContactJiafeng Wang

Shanghai Changhai Hospital

jfwang@smmu.edu.cn+86 137 7428 6926

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026